MONDAY, OCTOBER 26, 2026  /  10-MINUTE READ

CASH & CHAOS

MARKETS, MONEY AND THE MADNESS IN BETWEEN.

Sponsored by

Good morning. The AI bill is reaching shareholders. Meta’s proposed $35 billion financing brings the cost of expansion into focus, while Musk’s funding comments and CoreWeave’s disruption put neocloud economics under scrutiny.

Verizon raises its cash forecast, Barclays turns bullish on Tesla, and EQT signs a major gas merger. We also examine Moderna’s cancer results. Scoreboard prices are Friday’s closes, not Monday premarket quotes.

Meta’s $35 billion AI funding plan brings shareholders into the bill.

Meta headquarters sign in Menlo Park

Menlo Park, 2021 archive. Tony Avelar / AP, via Spectrum News.

Meta has launched roughly $35 billion of proposed public offerings to support its AI buildout: $22.5 billion of common stock through forward sale agreements and approximately $12.5 billion of mandatory convertible preferred securities.

The distinction matters for existing holders. Equity financing provides capital without adding an ordinary loan, but issuing more shares can reduce each existing share’s claim on future earnings. The investment must eventually generate enough additional profit to justify that larger ownership base.

Nvidia, AMD and Broadcom have indicated interest in buying up to $5 billion combined within the common-stock offering. Those indications are nonbinding, and the amount is included in the offering—not an additional $5 billion on top.

That creates a potentially important overlap: chip suppliers could become shareholders in a major customer. It would align their exposure more closely with Meta’s expansion, but their interest alone cannot establish whether the resulting AI investments will earn attractive returns.

Meta also outlined a separate, prospective $60 billion at-the-market share-sale program associated with its new Class C stock. That is potential future capacity, not money already raised. The common-stock forward agreements also mean announcement, sale and cash settlement need not happen together.

The preferred securities are expected to convert in August 2029; dividend and conversion terms remain subject to pricing. Those terms affect the financing cost and eventual dilution, so a precise per-share impact is premature.

Our read: the AI funding question now reaches beyond neocloud lenders to the ownership of a major platform. More capital can accelerate construction. For shareholders, the test is whether the extra capacity produces returns that outweigh the cost of financing it.

Read Meta’s financing terms →

Verizon wins customers, raises cash guidance—and signs an AWS deal.

Verizon name and logo above a retail store entrance

Verizon storefront, archive. Photo via Light Reading.

Verizon’s turnaround gained substance: 406,000 postpaid phone additions, a third consecutive guidance raise, and an AWS infrastructure agreement valued above $2 billion. But the quarter was an earnings beat with a revenue miss, rather than a clean sweep.

Adjusted EPS of $1.31 exceeded the approximately $1.27 pre-results Zacks consensus. Revenue of $34.31 billion, up 1.5%, fell short of roughly $34.81 billion. GAAP EPS was $1.25. Consensus: Data provided by Zacks Investment Research, Inc., www.zacksdata.com.

The customer economics are more interesting than the headline beat. Verizon reported promotional acquisition costs down 41% and retention costs down 30%, while phone churn improved year over year to 0.94%. It added 137,000 postpaid accounts. Winning customers with fewer promotional dollars offers a more durable route to profit than buying growth through bigger discounts.

The cash-flow tables add a qualification. Quarterly free cash flow rose $845 million to $7.80 billion. Of that increase, $594 million came from lower capital spending and $251 million from higher operating cash flow. Lower capex explains about 70% of the quarterly improvement—but only about 15% of the first nine months’ increase.

The raised outlook is stronger evidence. Full-year free-cash-flow guidance is now $22.44–$22.54 billion, up about $450 million at the midpoint, with the $16–$16.5 billion capex range unchanged. Adjusted EPS guidance rises to $5.04–$5.06. Management is forecasting better cash generation, not another reduction in its investment budget.

Growth is uneven. Fixed-wireless additions fell to 159,000 from 261,000 a year earlier; total broadband additions slipped to 314,000 from 322,000. The phone recovery should not be mistaken for acceleration across every product.

The AWS agreement adds an AI catalyst, but its value is not quarterly revenue. The earnings announcement does not establish its duration or margins. Verizon’s strongest evidence today is in customer economics and cash guidance; the new infrastructure relationship still needs financial detail.

Check Verizon’s cash-flow reconciliation →

SpaceX’s $40 billion financing raises the stakes for neoclouds.

TeraWulf logo on a barrier at the Lake Mariner campus

Lake Mariner, archive. TeraWulf, via Data Center Richness.

The AI funding debate sharpened over the weekend. Elon Musk said SpaceX had closed $40 billion of financing for GPUs, while warning that specialist AI-cloud providers face a wave of failures and consolidation.

Reuters reported his comments Sunday, but said it was unclear what “closed” meant or whether investors had agreed to debt pricing. Musk credited SpaceX’s investment-grade status and revenue outside AI, including Starlink and launches. His prediction about competitors is an interested participant’s view, not evidence that any named company is insolvent.

The financial distinction is real: a company with cash-generating operations elsewhere can support borrowing differently from a developer waiting for new campuses to start earning. Strong customer demand does not remove the need to fund construction, equipment and interest before revenue arrives.

TeraWulf offers a concrete counterpoint to a blanket funding freeze. Its Friday filing increased committed revolving capacity from $250 million to roughly $400 million and removed a $150 million letter-of-credit limit. Another $150 million remains conditional on additional lender commitments. That is useful flexibility, not proof every project is fully funded.

CoreWeave also has a separate operational issue. Its status page records renewed power and cooling disruption at US-EAST-15A over the weekend. At 12:27 a.m. ET Monday, power was restored and most affected nodes were back in service, with recovery continuing. The update does not quantify lost revenue or customer credits.

Our read: access to capital and dependable delivery are becoming harder to separate. Borrowing pays for installed capacity; reliable operations turn that capacity into a service customers can use. The outage does not prove a financing problem, and Musk’s warning does not establish its financial impact. Together, however, the developments explain why a large backlog alone cannot settle the investment case.

Read the financing report →

Barclays turns bullish on Tesla. The recovery is still uneven.

Tesla-branded Megapack battery storage units

Megapack installation, archive. Courtesy of Tesla.

Barclays upgraded Tesla to Overweight from Equalweight Monday and raised its target to $450 from $370. The firm cited a stronger core-business outlook, Robotaxi progress and a possible SpaceX combination. The new target is an analyst opinion; the potential merger is not an agreed transaction. Read the upgrade report.

Tesla’s Q3 shareholder deck shows why the operating case needs care. Revenue was $28.05 billion, approximately flat year over year, while operating profit fell 56% to $718 million. Operating expenses increased 39%, absorbing much of the gross-profit improvement.

There is progress beneath those totals. Active FSD subscriptions reached 1.74 million, up 67%; Tesla’s definition includes upfront purchases and monthly subscriptions, excluding free trials. FSD remains supervised driving software, distinct from the company’s unsupervised Robotaxi service.

Energy provides another useful contrast. Storage deployments rose 10% to 13.7 gigawatt-hours, but segment revenue fell 16% to $2.88 billion. Physical deployment growth and reported sales do not necessarily move together within a quarter.

Free cash flow recovered to $1.53 billion from a $1.09 billion outflow in Q2, yet remained 62% below the year-earlier quarter as capital spending increased. The improvement is real on a sequential basis and much weaker on an annual comparison.

Barclays is backing future improvement, rather than an already restored earnings base. That is a legitimate investment thesis, but it asks shareholders to give credit to businesses and possible corporate changes before their eventual economics are settled.

Compare Tesla’s growth and cash figures →

A CRM so smart, it updates itself.

HubSpot's CRM is so smart, it now updates itself. Calls get logged and summarized the moment they end. New leads get researched and a first outreach drafted, automatically. Deals move forward on their own, with next steps flagged before you have to ask. 

Even the one repetitive task you've been meaning to fix can now run itself, no code required. Customers using it are already seeing the difference. 

This isn't the CRM you have to work hard to figure out. It's the one already working before you log in.

The Mag 7 + three: Friday’s close.

Micron and AMD led this watchlist while most of the Mag 7 slipped. SPY fell 0.52%; QQQ was nearly flat, down 0.01%. Those are ETF price changes, not index returns.

StockCloseFriday
AAPL$347.73-0.14%
MSFT$524.51+0.66%
NVDA$210.96-0.59%
AMZN$248.00-0.95%
GOOGL$320.21-1.24%
META$642.62-0.96%
TSLA$372.22-0.63%
AMD$516.79+1.74%
AVGO$321.68-0.48%
MU$877.55+2.46%

October 23 regular-session adjusted closes versus October 22. Rounded prices; returns calculated before rounding. C&C editorial watchlist, not an official index.

Moderna’s cancer trial: the 42% result comes first.

Moderna headquarters entrance and company name

Cambridge headquarters, archive. Courtesy of Moderna.

Moderna’s detailed weekend data supports its ambition beyond respiratory vaccines. Adding intismeran to Merck’s Keytruda reduced the risk of melanoma recurrence or death by 42% in the primary Phase 3 analysis.

The randomized trial involved 1,137 patients following complete removal of stage IIB–IV melanoma, with median follow-up of 24.6 months. The comparison was against Keytruda alone; this is not a claim that 42% of patients were cured.

A modified analysis showed a 49% risk reduction, and a separate prespecified analysis after six months showed 58%. Those answer different questions and should not replace the primary result in a headline.

Severe treatment-related adverse events occurred in 14.2% of combination patients versus 13.4% with Keytruda alone. Manufacturing succeeded for more than 99% of patients assigned the individualized therapy.

Reliable production is part of the investment case: a treatment tailored to each tumor needs repeatable manufacturing as well as clinical benefit. These data support both, but approval, reimbursement and commercial margins remain unresolved. A promising therapy and a profitable product are different milestones.

Examine Moderna’s trial results →

EQT agrees to buy Range. The $50 billion figure needs context.

EQT logo on a natural gas drilling rig

Drilling equipment, archive. Courtesy of EQT Corporation.

EQT and Range Resources announced a definitive all-stock merger agreement Monday, creating a proposed combined natural-gas company with enterprise value above $50 billion. That figure describes the combined business, including debt—not the price paid for Range.

Each Range share would receive 0.987 EQT shares. Existing EQT holders would own approximately 73% of the combined company, with Range holders owning 27%. Because the consideration is stock, the value received moves with EQT’s share price; there is no fixed cash payout.

Management expects $325 million in annual base synergies within two years, across corporate costs, operations and marketing. The proposed combination would produce more than 9 billion cubic feet equivalent per day and hold over 30 years of inventory.

The financial logic is to spread costs and strengthen the ability to arrange long-term supply. The counterweight is commodity exposure: a larger resource base does not remove sensitivity to gas prices, and forecast savings still need to be delivered.

Closing is expected in Q1 2027, subject to regulatory and both companies’ shareholder approvals. The agreement gives investors specific terms to assess, but it is not a completed transaction. Integration and realized savings will determine how much of the promised value reaches each share.

Read the EQT–Range merger agreement summary →

Today’s calendar: activity first, earnings next.

Monday, October 26 · All times ET. The Chicago Fed National Activity Index is scheduled for 8:30 a.m.; Dallas Fed manufacturing follows at 10:30 a.m. Both were still ahead at our morning research cutoff.

Earnings: Verizon has reported; its call is scheduled for 8:30 a.m. Cadence, Welltower and Nucor report after the close. Fiscal.ai’s confirmed calendar was checked October 26. Tomorrow’s selected reports include SoFi, PayPal and Coca-Cola before the open, then Visa and Robinhood after the close.

The surveys offer an early read on activity and pricing pressure ahead of Wednesday’s Fed decision. Stronger demand can support sales while persistent inflation keeps financing costs elevated—a combination with different consequences for cash-rich companies and borrowers.

Prediction markets lean toward a Fed hold.

Polymarket’s October Fed-decision market displayed roughly 96% for no rate change when checked around 6 a.m. ET Monday. That is a market-implied probability, not a Federal Reserve forecast. The contract concerns the October decision, not the direction of stocks afterward; a hold can still come with a consequential change in the accompanying message.

Monday’s analyst moves beyond Tesla.

Lockheed Martin: Morgan Stanley upgraded the stock to Overweight from Equalweight, with an $835 target. Ross Stores: UBS upgraded to Buy from Neutral, with a $315 target. Both upgrades were reported October 26. Price targets express analysts’ views, not company promises or guaranteed returns.

Crypto, briefly.

Bitcoin: about $80,448. Ether: about $2,335. Coinbase USD spot snapshots retrieved at 6:00 a.m. ET, October 26; these are timestamped levels, not daily returns. Crypto trades through the weekend, so these quotes are not directly comparable with Friday’s stock closes.

Forwarded this email? Get Cash & Chaos in your inbox.

Independent market commentary. C&C interpretations are analysis; company targets and reported deal terms are not guarantees.